Trade Summary

2 months ago, Nunn Jason Raleigh, serving as Dir at Zenas Biopharma, Inc. (ZBIO), purchased 63,158 shares at $19.00 per share, for a total transaction value of $1,200,002.00. Following this transaction, Nunn Jason Raleigh now holds 3,119,959 shares of ZBIO.

This purchase represents a 2.00% increase in Nunn Jason Raleigh's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, October 9, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, October 14, 2025, 5 days after the trade was made.

Zenas Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.